Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.640101
-0.0100 (-1.54%)
May 15, 2026, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Cap
37262153512
Market Cap Growth
-14.06%174.82%-96.16%-59.65%-70.14%-
Enterprise Value
-1.88-4.31-3.652.76147.08504.8
Last Close Price
0.643.255.3118.54235.001590.00
PE Ratio
--0.39-0.26-5.70-7.08-41.89
PS Ratio
0.591.320.5114.92140.35-
PB Ratio
0.310.480.265.1016.8469.41
P/TBV Ratio
0.310.240.220.8614.52120.89
P/FCF Ratio
--0.84-0.34-8.29-9.79-52.29
P/OCF Ratio
--0.84-0.34-8.47-9.81-52.30
EV/Sales Ratio
--0.87-0.7812.76135.00-
EV/EBITDA Ratio
-0.580.47-6.74-8.78-51.99
EV/EBIT Ratio
-0.540.44-6.26-8.52-50.79
EV/FCF Ratio
-0.550.51-7.09-9.41-51.55
Debt / Equity Ratio
0.000.020.070.000.040.03
Debt / EBITDA Ratio
-0.05-0.10-0.13-0.05-0.05-0.03
Debt / FCF Ratio
-0.06-0.09-0.14-0.05-0.05-0.03
Net Debt / Equity Ratio
-0.69-0.77-0.61-0.71-0.60-0.97
Net Debt / EBITDA Ratio
0.601.400.741.090.320.74
Net Debt / FCF Ratio
0.641.340.811.150.350.73
Asset Turnover
0.320.360.350.310.100
Inventory Turnover
4.392.932.441.330.44-
Quick Ratio
2.356.303.534.611.903.35
Current Ratio
3.116.994.415.662.893.78
Return on Equity (ROE)
-101.16%-72.10%-71.95%-74.84%-226.07%-153.95%
Return on Assets (ROA)
-84.47%-58.00%-63.16%-62.56%-152.99%-113.04%
Return on Invested Capital (ROIC)
-284.08%-240.42%-230.84%-218.77%-787.00%-3404.39%
Return on Capital Employed (ROCE)
-103.22%-67.37%-74.66%-78.12%-202.71%-145.17%
Earnings Yield
-293.21%-257.23%-379.28%-17.53%-14.11%-2.39%
FCF Yield
-256.95%-119.36%-295.43%-12.07%-10.22%-1.91%
Buyback Yield / Dilution
-365.07%-156.13%32.06%0.00%0.00%89.26%
Total Shareholder Return
-365.07%-156.13%32.06%0.00%0.00%89.26%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q